Home LiteratureArticle Details
PMID: 19426218 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Review

PD-1 signaling in primary T cells.

Immunological reviews ·Vol. 229 ·No. 1 ·2009-05-00 ·Pages 114-25

Riley JL

Abstract

Programmed death-1 (PD-1) is a cell surface molecule that regulates the adaptive immune response. Engagement of PD-1 by its ligands PD-L1 or PD-L2 transduces a signal that inhibits T-cell proliferation, cytokine production, and cytolytic function. While a great deal is known concerning the biologic roles PD-1 plays in regulating the primary immune response and in T-cell exhaustion, comparatively little is known regarding how PD-1 ligation alters signaling pathways. PD-1 ligation is known to inhibit membrane-proximal T-cell signaling events, while ligation of the related inhibitory molecule cytotoxic T-lymphocyte antigen-4 appears to target more downstream signaling pathways. A major obstacle to an in-depth understanding of PD-1 signaling is the lack of physiologic models in which to study signal transduction. This review focuses on: (i) signaling pathways altered by PD-1 ligation, (ii) factors recruited upon PD-1 phosphorylation, and (iii) exploring the hypothesis that PD-1 ligation induces distinct signals during various stages of immune-cell differentiation. Lastly, we describe models to dissect the function of the PD-1 cytoplasmic tail using primary cells in the absence of agonist antibodies.

MeSH Terms
Animals Antigens, CD/genetics,immunology,metabolism Antigens, Surface/genetics,immunology,metabolism Apoptosis Regulatory Proteins/genetics,immunology,metabolism CD28 Antigens/immunology,metabolism CTLA-4 Antigen Humans Mice Programmed Cell Death 1 Receptor Protein Tyrosine Phosphatase, Non-Receptor Type 11/immunology,metabolism Protein Tyrosine Phosphatase, Non-Receptor Type 6/immunology,metabolism Signal Transduction/immunology T-Lymphocytes/immunology,metabolism
Chemicals
Antigens, CD Antigens, Surface Apoptosis Regulatory Proteins CD28 Antigens CTLA-4 Antigen CTLA4 protein, human Ctla4 protein, mouse PDCD1 protein, human Pdcd1 protein, mouse Programmed Cell Death 1 Receptor Protein Tyrosine Phosphatase, Non-Receptor Type 11 Protein Tyrosine Phosphatase, Non-Receptor Type 6
Authors & Affiliations
1 authors, click to expand affiliations / ORCID
Riley James L
Department of Pathology and Laboratory Medicine, Abramson Family Cancer Research Institute, The University of Pennsylvania, Philadelphia, PA, USA. rileyj@exchange.upenn.edu
References (93)
93 references, click to expand
  1. Unifying concepts in CD28, ICOS and CTLA4 co-receptor signalling.
    Nat Rev Immunol. 2003 Jul;3(7):544-56 PMID: 12876557
  2. BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1.
    Nat Immunol. 2003 Jul;4(7):670-9 PMID: 12796776
  3. The CD28 signaling pathway regulates glucose metabolism.
    Immunity. 2002 Jun;16(6):769-77 PMID: 12121659
  4. The interchain disulfide linkage is not a prerequisite but enhances CD28 costimulatory function.
    Cell Immunol. 2006 Dec;244(2):125-9 PMID: 17467674
  5. Siglecs and their roles in the immune system.
    Nat Rev Immunol. 2007 Apr;7(4):255-66 PMID: 17380156
  6. Dendritic cells in transplantation and immune-based therapies.
    Biol Blood Marrow Transplant. 2007 Jan;13(1 Suppl 1):23-32 PMID: 17222766
  7. CTLA-4 ligation delivers a unique signal to resting human CD4 T cells that inhibits interleukin-2 secretion but allows Bcl-X(L) induction.
    J Immunol. 1998 Jan 1;160(1):12-5 PMID: 9551948
  8. Correction of multi-gene deficiency in vivo using a single 'self-cleaving' 2A peptide-based retroviral vector.
    Nat Biotechnol. 2004 May;22(5):589-94 PMID: 15064769
  9. Restoring function in exhausted CD8 T cells during chronic viral infection.
    Nature. 2006 Feb 9;439(7077):682-7 PMID: 16382236
  10. Lentiviral vectors encoding human immunodeficiency virus type 1 (HIV-1)-specific T-cell receptor genes efficiently convert peripheral blood CD8 T lymphocytes into cytotoxic T lymphocytes with potent in vitro and in vivo HIV-1-specific inhibitory activity.
    J Virol. 2008 Mar;82(6):3078-89 PMID: 18184707
  11. STAT5 is essential for Akt/p70S6 kinase activity during IL-2-induced lymphocyte proliferation.
    J Immunol. 2007 Oct 15;179(8):5301-8 PMID: 17911616
  12. Directed evolution of human T-cell receptors with picomolar affinities by phage display.
    Nat Biotechnol. 2005 Mar;23(3):349-54 PMID: 15723046
  13. PD-1:PD-L inhibitory pathway affects both CD4(+) and CD8(+) T cells and is overcome by IL-2.
    Eur J Immunol. 2002 Mar;32(3):634-43 PMID: 11857337
  14. PD-1 and PD-1 ligands: from discovery to clinical application.
    Int Immunol. 2007 Jul;19(7):813-24 PMID: 17606980
  15. Multiple requirements for SHPTP2 in epidermal growth factor-mediated cell cycle progression.
    Mol Cell Biol. 1996 Mar;16(3):1189-202 PMID: 8622663
  16. Association of Grb-2 and PI3K p85 with phosphotyrosile peptides derived from BTLA.
    Biochem Biophys Res Commun. 2006 Jul 14;345(4):1440-5 PMID: 16725108
  17. CD28 and inducible costimulatory protein Src homology 2 binding domains show distinct regulation of phosphatidylinositol 3-kinase, Bcl-xL, and IL-2 expression in primary human CD4 T lymphocytes.
    J Immunol. 2003 Jul 1;171(1):166-74 PMID: 12816995
  18. Negative regulation of natural killer cell function by EAT-2, a SAP-related adaptor.
    Nat Immunol. 2005 Oct;6(10):1002-10 PMID: 16127454
  19. Phosphotyrosines in the killer cell inhibitory receptor motif of NKB1 are required for negative signaling and for association with protein tyrosine phosphatase 1C.
    J Exp Med. 1996 Jul 1;184(1):295-300 PMID: 8691146
  20. Establishment of NOD-Pdcd1-/- mice as an efficient animal model of type I diabetes.
    Proc Natl Acad Sci U S A. 2005 Aug 16;102(33):11823-8 PMID: 16087865
  21. Evidence that SHIP-1 contributes to phosphatidylinositol 3,4,5-trisphosphate metabolism in T lymphocytes and can regulate novel phosphoinositide 3-kinase effectors.
    J Immunol. 2002 Nov 15;169(10):5441-50 PMID: 12421919
  22. PD-1 and its ligands in tolerance and immunity.
    Annu Rev Immunol. 2008;26:677-704 PMID: 18173375
  23. Control of peripheral T-cell tolerance and autoimmunity via the CTLA-4 and PD-1 pathways.
    Immunol Rev. 2008 Aug;224:166-82 PMID: 18759926
  24. Role of SH-PTP2, a protein-tyrosine phosphatase with Src homology 2 domains, in insulin-stimulated Ras activation.
    Mol Cell Biol. 1994 Oct;14(10):6674-82 PMID: 7935386
  25. A single amino acid alteration in cytoplasmic domain determines IL-2 promoter activation by ligation of CD28 but not inducible costimulator (ICOS).
    J Exp Med. 2003 Jan 20;197(2):257-62 PMID: 12538664
  26. Analysis of the role of negative T cell costimulatory pathways in CD4 and CD8 T cell-mediated alloimmune responses in vivo.
    J Immunol. 2005 Jun 1;174(11):6648-56 PMID: 15905503
  27. Adapter function of protein-tyrosine phosphatase 1D in insulin receptor/insulin receptor substrate-1 interaction.
    J Biol Chem. 1995 Dec 8;270(49):29189-93 PMID: 7493946
  28. The tyrosine phosphatase SHP-2 is required for sustained activation of extracellular signal-regulated kinase and epithelial morphogenesis downstream from the met receptor tyrosine kinase.
    Mol Cell Biol. 2000 Nov;20(22):8513-25 PMID: 11046147
  29. Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death.
    EMBO J. 1992 Nov;11(11):3887-95 PMID: 1396582
  30. Regulation of cell signaling by the protein tyrosine phosphatases, CD45 and SHP-1.
    Immunol Res. 1997 Feb;16(1):101-13 PMID: 9048211
  31. Reinvigorating exhausted HIV-specific T cells via PD-1-PD-1 ligand blockade.
    J Exp Med. 2006 Oct 2;203(10):2223-7 PMID: 17000870
  32. The PD-1-PD-L pathway in immunological tolerance.
    Trends Immunol. 2006 Apr;27(4):195-201 PMID: 16500147
  33. Investigations into the regulation and function of the SH2 domain-containing protein-tyrosine phosphatase, SHP-1.
    Immunol Res. 2006;35(1-2):127-36 PMID: 17003515
  34. The 'Shp'ing news: SH2 domain-containing tyrosine phosphatases in cell signaling.
    Trends Biochem Sci. 2003 Jun;28(6):284-93 PMID: 12826400
  35. B and T lymphocyte attenuator exhibits structural and expression polymorphisms and is highly Induced in anergic CD4+ T cells.
    J Immunol. 2005 Mar 15;174(6):3377-85 PMID: 15749870
  36. PD-1 is a regulator of virus-specific CD8+ T cell survival in HIV infection.
    J Exp Med. 2006 Oct 2;203(10):2281-92 PMID: 16954372
  37. Involvement of SH2-containing phosphotyrosine phosphatase Syp in erythropoietin receptor signal transduction pathways.
    J Biol Chem. 1995 Mar 10;270(10):5631-5 PMID: 7534299
  38. Cloning of a complementary DNA for a protein-tyrosine kinase that specifically phosphorylates a negative regulatory site of p60c-src.
    Nature. 1991 May 2;351(6321):69-72 PMID: 1709258
  39. A cell-based artificial antigen-presenting cell coated with anti-CD3 and CD28 antibodies enables rapid expansion and long-term growth of CD4 T lymphocytes.
    Clin Immunol. 2002 Dec;105(3):259-72 PMID: 12498807
  40. SHP2 and SOCS3 contribute to Tyr-759-dependent attenuation of interleukin-6 signaling through gp130.
    J Biol Chem. 2003 Jan 3;278(1):661-71 PMID: 12403768
  41. Phosphoinositide lipid phosphatases: natural regulators of phosphoinositide 3-kinase signaling in T lymphocytes.
    J Biol Chem. 2008 Feb 1;283(5):2465-9 PMID: 18073217
  42. Nonreceptor protein-tyrosine phosphatases in immune cell signaling.
    Annu Rev Immunol. 2007;25:473-523 PMID: 17291189
  43. Grb2 forms an inducible protein complex with CD28 through a Src homology 3 domain-proline interaction.
    J Biol Chem. 1998 Aug 14;273(33):21194-202 PMID: 9694876
  44. Jurkat T cells and development of the T-cell receptor signalling paradigm.
    Nat Rev Immunol. 2004 Apr;4(4):301-8 PMID: 15057788
  45. Mutation of the SHP-2 binding site in growth hormone (GH) receptor prolongs GH-promoted tyrosyl phosphorylation of GH receptor, JAK2, and STAT5B.
    Mol Endocrinol. 2000 Sep;14(9):1338-50 PMID: 10976913
  46. Role of the inositol phosphatase SHIP in negative regulation of the immune system by the receptor Fc(gamma)RIIB.
    Nature. 1996 Sep 19;383(6597):263-6 PMID: 8805703
  47. Loss of Siglec expression on T lymphocytes during human evolution.
    Proc Natl Acad Sci U S A. 2006 May 16;103(20):7765-70 PMID: 16682635
  48. The B7-CD28 superfamily.
    Nat Rev Immunol. 2002 Feb;2(2):116-26 PMID: 11910893
  49. PD-1 immunoreceptor inhibits B cell receptor-mediated signaling by recruiting src homology 2-domain-containing tyrosine phosphatase 2 to phosphotyrosine.
    Proc Natl Acad Sci U S A. 2001 Nov 20;98(24):13866-71 PMID: 11698646
  50. PD-1 deficiency reveals various tissue-specific autoimmunity by H-2b and dose-dependent requirement of H-2g7 for diabetes in NOD mice.
    Proc Natl Acad Sci U S A. 2008 Mar 4;105(9):3533-8 PMID: 18299579
  51. Recruitment of C-terminal Src kinase by the leukocyte inhibitory receptor CD85j.
    Biochem Biophys Res Commun. 2004 Nov 12;324(2):640-7 PMID: 15474475
  52. PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression.
    Nature. 2006 Sep 21;443(7109):350-4 PMID: 16921384
  53. PD-1 and its ligands in T-cell immunity.
    Curr Opin Immunol. 2007 Jun;19(3):309-14 PMID: 17433872
  54. Molecular signature of CD8+ T cell exhaustion during chronic viral infection.
    Immunity. 2007 Oct;27(4):670-84 PMID: 17950003
  55. The B7 family revisited.
    Annu Rev Immunol. 2005;23:515-48 PMID: 15771580
  56. Engineering artificial antigen-presenting cells to express a diverse array of co-stimulatory molecules.
    Mol Ther. 2007 May;15(5):981-8 PMID: 17375070
  57. Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction.
    Nat Med. 2006 Oct;12(10):1198-202 PMID: 16917489
  58. Programmed death-1 ligand 1 interacts specifically with the B7-1 costimulatory molecule to inhibit T cell responses.
    Immunity. 2007 Jul;27(1):111-22 PMID: 17629517
  59. Identification of the tyrosine phosphatase PTP1C as a B cell antigen receptor-associated protein involved in the regulation of B cell signaling.
    J Exp Med. 1995 Jun 1;181(6):2077-84 PMID: 7539038
  60. Differential contribution of the immunoreceptor tyrosine-based inhibitory motifs of human leukocyte-associated Ig-like receptor-1 to inhibitory function and phosphatase recruitment.
    Int Immunol. 2003 Nov;15(11):1349-58 PMID: 14565933
  61. SHP-1- and phosphotyrosine-independent inhibitory signaling by a killer cell Ig-like receptor cytoplasmic domain in human NK cells.
    J Immunol. 2002 May 15;168(10):5047-57 PMID: 11994457
  62. Stable antibody expression at therapeutic levels using the 2A peptide.
    Nat Biotechnol. 2005 May;23(5):584-90 PMID: 15834403
  63. Ligation of CD28 receptor by B7 induces formation of D-3 phosphoinositides in T lymphocytes independently of T cell receptor/CD3 activation.
    Eur J Immunol. 1993 Oct;23(10):2572-7 PMID: 8405057
  64. Systematic identification of immunoreceptor tyrosine-based inhibitory motifs in the human proteome.
    Cell Signal. 2004 Apr;16(4):435-56 PMID: 14709333
  65. CTLA-4: new insights into its biological function and use in tumor immunotherapy.
    Nat Immunol. 2002 Jul;3(7):611-8 PMID: 12087419
  66. CTLA-4 and PD-1 receptors inhibit T-cell activation by distinct mechanisms.
    Mol Cell Biol. 2005 Nov;25(21):9543-53 PMID: 16227604
  67. Resting dendritic cells induce peripheral CD8+ T cell tolerance through PD-1 and CTLA-4.
    Nat Immunol. 2005 Mar;6(3):280-6 PMID: 15685176
  68. SHP-1 and SHP-2 associate with immunoreceptor tyrosine-based switch motif of programmed death 1 upon primary human T cell stimulation, but only receptor ligation prevents T cell activation.
    J Immunol. 2004 Jul 15;173(2):945-54 PMID: 15240681
  69. Modulation of TCR-induced transcriptional profiles by ligation of CD28, ICOS, and CTLA-4 receptors.
    Proc Natl Acad Sci U S A. 2002 Sep 3;99(18):11790-5 PMID: 12195015
  70. Novel strategies to eliminate persistent viral infections.
    Trends Immunol. 2008 Mar;29(3):116-24 PMID: 18258483
  71. Programmed death 1 ligand (PD-L) 1 and PD-L2 limit autoimmune kidney disease: distinct roles.
    J Immunol. 2007 Dec 1;179(11):7466-77 PMID: 18025191
  72. Variability and robustness in T cell activation from regulated heterogeneity in protein levels.
    Science. 2008 Aug 22;321(5892):1081-4 PMID: 18719282
  73. GRID: a novel Grb-2-related adapter protein that interacts with the activated T cell costimulatory receptor CD28.
    J Immunol. 2000 Jun 1;164(11):5805-14 PMID: 10820259
  74. Lack of SHPTP1 results in src-family kinase hyperactivation and thymocyte hyperresponsiveness.
    Proc Natl Acad Sci U S A. 1996 Sep 3;93(18):9624-9 PMID: 8790380
  75. Genomic expression programs and the integration of the CD28 costimulatory signal in T cell activation.
    Proc Natl Acad Sci U S A. 2002 Sep 3;99(18):11796-801 PMID: 12195013
  76. Grb2 and Gads exhibit different interactions with CD28 and play distinct roles in CD28-mediated costimulation.
    J Immunol. 2006 Jul 15;177(2):1085-91 PMID: 16818765
  77. The CD28 family: a T-cell rheostat for therapeutic control of T-cell activation.
    Blood. 2005 Jan 1;105(1):13-21 PMID: 15353480
  78. Deficiency of PTEN in Jurkat T cells causes constitutive localization of Itk to the plasma membrane and hyperresponsiveness to CD3 stimulation.
    Mol Cell Biol. 2000 Sep;20(18):6945-57 PMID: 10958690
  79. Siglec-5 (CD170) can mediate inhibitory signaling in the absence of immunoreceptor tyrosine-based inhibitory motif phosphorylation.
    J Biol Chem. 2005 May 20;280(20):19843-51 PMID: 15769739
  80. B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion.
    Nat Med. 1999 Dec;5(12):1365-9 PMID: 10581077
  81. LAIR-1, a novel inhibitory receptor expressed on human mononuclear leukocytes.
    Immunity. 1997 Aug;7(2):283-90 PMID: 9285412
  82. Fuel feeds function: energy metabolism and the T-cell response.
    Nat Rev Immunol. 2005 Nov;5(11):844-52 PMID: 16239903
  83. Leukocyte-associated Ig-like receptor-1 has SH2 domain-containing phosphatase-independent function and recruits C-terminal Src kinase.
    Eur J Immunol. 2006 Jan;36(1):190-8 PMID: 16380958
  84. The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection.
    Nat Immunol. 2007 Mar;8(3):239-45 PMID: 17304234
  85. PD-L2 is a second ligand for PD-1 and inhibits T cell activation.
    Nat Immunol. 2001 Mar;2(3):261-8 PMID: 11224527
  86. Roles of the SHP-1 tyrosine phosphatase in the negative regulation of cell signalling.
    Semin Immunol. 2000 Aug;12(4):361-78 PMID: 10995583
  87. Growth factor receptor-bound protein 2 SH2/SH3 domain binding to CD28 and its role in co-signaling.
    J Biol Chem. 1998 Jan 2;273(1):296-301 PMID: 9417079
  88. B and T lymphocyte attenuator-mediated signal transduction provides a potent inhibitory signal to primary human CD4 T cells that can be initiated by multiple phosphotyrosine motifs.
    J Immunol. 2006 Jun 1;176(11):6603-14 PMID: 16709818
  89. Control of HIV-1 immune escape by CD8 T cells expressing enhanced T-cell receptor.
    Nat Med. 2008 Dec;14(12):1390-5 PMID: 18997777
  90. Constitutive association of SHP-1 with leukocyte-associated Ig-like receptor-1 in human T cells.
    J Immunol. 2001 Feb 1;166(3):1763-70 PMID: 11160222
  91. The road to recovery: translating PD-1 biology into clinical benefit.
    Trends Immunol. 2007 Feb;28(2):48-50 PMID: 17188572
  92. Turning on the off switch: regulation of anti-viral T cell responses in the liver by the PD-1/PD-L1 pathway.
    J Hepatol. 2006 Oct;45(4):468-72 PMID: 16901572
  93. Direct regulation of ZAP-70 by SHP-1 in T cell antigen receptor signaling.
    Science. 1996 May 24;272(5265):1173-6 PMID: 8638162
Article Info
Journal
Immunological reviews
Abbr.
Immunol Rev
ISSN
1600-065X
Published
2009-05-00
Pages
114-25
Language
English
Region
England
NLM ID
7702118
PMCID
PMC3424066
Subset
IM
Grants
NIAID NIH HHS · R01 AI057838 · United States
NIAID NIH HHS · AI080192 · United States
NIAID NIH HHS · AI057838 · United States
NIAID NIH HHS · P01 AI080192 · United States
NIAID NIH HHS · PD-1 PO1AI080192 · United States
NCI NIH HHS · R01 CA113783 · United States
NCI NIH HHS · CA113783 · United States
NIAID NIH HHS · R01 AI057838-05 · United States
NIAID NIH HHS · P01 AI080192-010003 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com